Summary & Overview
HCPCS Level II C1763: Connective Tissue, Non-Human (Includes Synthetic)
HCPCS Level II code C1763 identifies non-human connective tissue products, including synthetic graft materials used for implantation or reconstruction. This category matters nationally because connective tissue grafts are integral to a range of surgical specialties—orthopedics, general surgery, plastic/reconstructive surgery and wound care—and affect supply, coding consistency, and reimbursement across payers.
Key payers in scope for national benchmarking include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of these products, payer coverage scope, and common billing considerations. The publication outlines typical sites of service and the service type associated with C1763, and summarizes common modifiers and billing patterns when data are available.
The report provides practical benchmarks and policy-relevant notes on coding clarity, claims handling, and payer coverage trends to support coding accuracy and administrative planning. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code C1763 denotes connective tissue, non-human (includes synthetic). This code is used for billing implanted or grafted connective tissue materials derived from non-human sources or synthetic substitutes.
Service type: Tissue implant/graft supply
Typical site of service: Inpatient and outpatient surgical settings, including operating rooms and procedure suites where grafting or implantation of connective tissue products is performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with a full-thickness soft-tissue defect after trauma or surgical debridement presents for reconstruction. The surgeon selects a non-human connective tissue graft (C1763) — for example, a biologic dermal matrix of porcine or bovine origin or a synthetic collagen scaffold — to reinforce soft tissue, provide coverage, and support wound healing. Typical workflow: preoperative evaluation in the outpatient clinic with documentation of the wound size, prior infection status, and indication for grafting; informed consent and selection of the graft product; intraoperative placement of the connective tissue graft during wound closure or reconstructive procedure in an operating room or ambulatory surgery center; securement of the graft to native tissues, adjunctive procedures as needed (debridement, irrigation, hemostasis); postoperative wound care with follow-up visits for dressing changes and assessment of graft incorporation.
Typical site of service: hospital operating room, ambulatory surgery center, or wound care procedure room.
Typical patient scenario: a 58-year-old patient with a chronic non-healing lower extremity ulcer after vascular intervention undergoes surgical debridement and placement of a non-human connective tissue matrix to promote tissue regeneration and provide scaffold for re-epithelialization. The procedure is billed with product code C1763 and may be accompanied by surgical CPT codes for debridement or excisional procedures and appropriate modifiers reflecting circumstances such as bilateral site, assistant surgeon, or unusual procedural difficulty.
Coding Specifications
| Modifier | Description | When to Use |
|---|